Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

BD Evolve On-body Injector: Clinical Feasibility and Performance in the Abdomen and Arm

NCT05553418 is registered in ClinicalTrials.gov with Becton, Dickinson and Company as lead sponsor.

NCT NCT05553418
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05553418 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
BD Evolve On-body Injector: Clinical Feasibility and Performance in the Abdomen and Arm
Lead sponsor
Becton, Dickinson and Company
Phase
Not applicable
Overall status
Completed
Start date
September 5, 2022
Completion date
February 8, 2023
Enrollment
70 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy volunteers